MAPT and Alzheimer disease: Together with the CSF Aβ42/Aβ40 ratio, the cornerstone markers totaled tau (T-tau) and phosphorylated tau (P-tau) have been proposed as biomarkers for biologically defining AD and are considered diagnostic in the research criteria for AD [130,131].